Stimulation of 5-HT1A receptors reduces apoptosis after transient forebrain ischemia in the rat

被引:30
作者
Schaper, C [1 ]
Zhu, Y [1 ]
Kouklei, M [1 ]
Culmsee, C [1 ]
Krieglstein, J [1 ]
机构
[1] Univ Marburg, Fachbereich Pharm, Inst Pharmakol & Toxikol, D-35032 Marburg, Germany
关键词
5-HT1A agonist; forebrain ischemia; WAY; 100635; apoptosis; neuroprotection;
D O I
10.1016/S0006-8993(00)02876-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
It has recently been shown that 5-HT1A receptor stimulation reduced the infarct volume after occlusion of the middle cerebral artery in rats. Since then is increasing evidence that apoptosis is involved in neurodegenerative diseases and stroke, we investigated whether the 5-HT1A agonist Bay x 3702 could protect neurons against apoptotic damage in a rat model of transient forebrain cerebral ischemia. Bay x 3702 (4 mug/kg i.v.) caused a 10% reduction of neuronal damage in the hippocampal CA1 subfield. Higher doses of Bay x 3702 (40 and 12 mug/kg i.v.) did not cause any neuroprotective effect, most likely because of the strong reduction of mean arterial blood pressure during the period of Bay x 3702 infusion. Bay x 3702 (4 mug/kg i.v.) diminished DNA laddering in the hippocampus and striatum 4 days after 10 min forebrain ischemia. These results were confirmed by TUNEL-staining. The anti-apoptotic effect was abolished by additional treatment with the 5-HT1A receptor antagonist WAY 100635 (1 mg/kg). Taken together, the results suggest that Bay x 3702 can rescue hippocampal as well as striatal neurons from apoptotic cell death in vi iio via stimulation of 5-HT1A receptors. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:41 / 50
页数:10
相关论文
共 51 条
[11]   A cautionary note on the use of the TUNEL stain to determine apoptosis [J].
CharriautMarlangue, C ;
BenAri, Y .
NEUROREPORT, 1995, 7 (01) :61-64
[12]   DIFFERENTIAL MODULATION OF 3 SEPARATE K-CONDUCTANCES IN HIPPOCAMPAL CA1 NEURONS BY SEROTONIN [J].
COLINO, A ;
HALLIWELL, JV .
NATURE, 1987, 328 (6125) :73-77
[13]   IMPAIRED ACQUISITION OF THE MORRIS WATER MAZE FOLLOWING GLOBAL ISCHEMIC DAMAGE IN THE GERBIL [J].
CORBETT, D ;
EVANS, SJ ;
NURSE, SM .
NEUROREPORT, 1992, 3 (02) :204-206
[14]   2 DISTINCT EFFECTS OF 5-HYDROXYTRYPTAMINE ON SINGLE CORTICAL-NEURONS [J].
DAVIES, MF ;
DEISZ, RA ;
PRINCE, DA ;
PEROUTKA, SJ .
BRAIN RESEARCH, 1987, 423 (1-2) :347-352
[15]  
De Vry Jean, 1997, Drugs of the Future, V22, P341
[16]  
DEVRY J, 1995, PSYCHOPHARMACOLOGY, V121, P1
[17]   PERSPECTIVES IN S-100 PROTEIN BIOLOGY [J].
DONATO, R .
CELL CALCIUM, 1991, 12 (10) :713-726
[18]   IN-SITU EVIDENCE FOR DNA FRAGMENTATION IN HUNTINGTONS-DISEASE STRIATUM AND ALZHEIMERS-DISEASE TEMPORAL LOBES [J].
DRAGUNOW, M ;
FAULL, RLM ;
LAWLOR, P ;
BEILHARZ, EJ ;
SINGLETON, K ;
WALKER, EB ;
MEE, E .
NEUROREPORT, 1995, 6 (07) :1053-1057
[19]   Very delayed infarction after mild focal cerebral ischemia: A role for apoptosis? [J].
Du, C ;
Hu, R ;
Csernansky, CA ;
Hsu, CY ;
Choi, DW .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1996, 16 (02) :195-201
[20]   A PHARMACOLOGICAL PROFILE OF THE SELECTIVE SILENT 5-HT1A RECEPTOR ANTAGONIST, WAY-100635 [J].
FORSTER, EA ;
CLIFFE, IA ;
BILL, DJ ;
DOVER, GM ;
JONES, D ;
REILLY, Y ;
FLETCHER, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 281 (01) :81-88